Tower Research Capital LLC (Trc) Forma Therapeutics Holdings, Inc. Transaction History

Tower Research Capital LLC (Trc)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$7.12 - $20.24 $36,803 - $104,620	5,169 Added 342.09%	6,680 $133,000
Q2 2022 Aug 15, 2022	SELL	$5.1 - $10.0 $8,098 - $15,880	-1,588 Reduced 51.24%	1,511 $10,000
Q1 2022 May 12, 2022	BUY	$8.34 - $14.69 $14,044 - $24,737	1,684 Added 119.01%	3,099 $29,000
Q4 2021 Feb 14, 2022	SELL	$13.6 - $24.89 $28,845 - $52,791	-2,121 Reduced 59.98%	1,415 $20,000
Q3 2021 Nov 15, 2021	BUY	$21.22 - $25.7 $24,891 - $30,146	1,173 Added 49.64%	3,536 $82,000
Q2 2021 Aug 16, 2021	SELL	$22.86 - $30.95 $42,885 - $58,062	-1,876 Reduced 44.26%	2,363 $59,000
Q1 2021 May 17, 2021	BUY	$24.58 - $42.82 $90,233 - $157,192	3,671 Added 646.3%	4,239 $118,000
Q4 2020 Feb 16, 2021	SELL	$34.9 - $51.08 $78,071 - $114,265	-2,237 Reduced 79.75%	568 $20,000
Q3 2020 Nov 16, 2020	BUY	$32.95 - $50.25 $85,966 - $131,102	2,609 Added 1331.12%	2,805 $140,000
Q2 2020 Aug 13, 2020	BUY	$39.0 - $46.49 $7,644 - $9,112	196 New	196 $9,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.